Interventional Cardiology Medical Group
West Hills, California 91308
8 studies enrolling now · 14 studies all time
What they study most
Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation (AF), Cardiovascular Disease, Cardiovascular Risk, Chronic Heart Failure With Preserved Ejection Fraction, Difficult to Control Hypertension, Elevated Lp(a), Heart Diseases, Heart Failure, Iron-deficiency
Studies at this site
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
- Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease — Recruiting now
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation — Recruiting now
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable — Recruiting now
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
- Lumason® Infusion vs. Bolus Administrations — Recruiting now
- To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension — Recruiting now
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
- EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
- Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
- Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed